Company Filing History:
Years Active: 2016-2022
Title: Innovations of Marie-Paule Bouche
Introduction
Marie-Paule Bouche is a notable inventor based in Gentbrugge, Belgium. She has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that interact with chemokine receptors. With a total of three patents to her name, her work has implications for the treatment of various diseases.
Latest Patents
Her latest patents focus on chemokine receptor binding polypeptides. The first patent describes polypeptides that specifically bind to the C-X-C Motif chemokine receptor 2 (CXCR2). These polypeptides are capable of modulating signal transduction from CXCR2. The invention also encompasses nucleic acids, vectors, and host cells that can express these polypeptides. Additionally, it includes pharmaceutical compositions that utilize these polypeptides for treating diseases associated with aberrant functioning of CXCR2. The second patent reiterates similar findings, emphasizing the importance of these polypeptides in therapeutic applications.
Career Highlights
Marie-Paule Bouche has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Ablynx NV. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in medicine.
Collaborations
Some of her notable coworkers include Zarin Brown and Michelle Bradley. Their collaborative efforts have likely enhanced the research and development of her patented inventions.
Conclusion
Marie-Paule Bouche's work in the field of chemokine receptor binding polypeptides showcases her innovative spirit and dedication to advancing medical science. Her contributions are paving the way for new treatments that could significantly impact patient care.